Stakeholders Deliberate on Developing US Social Media Guidance

摘要

At a packed public hearing on 12-13 November, the US Food and Drug Administration heard from around 70 speakers on how the agency should be regulating internet and social media promotion of medical products. An analysis of the key points addressed at the meeting - which had a capacity audience of 350 - and pointers to what the pharmaceutical and medtech industries need to do next were provided by attorney Arnie Friede and healthcare media specialist Carlen Lea Lesser during a teleconference organised by FOI Services on 19 November.